Category: "Treatment"

Innovative brain implant could improve Epilepsy and Parkinson’s treatment

Innovative brain implant could improve Epilepsy and Parkinson’s treatment

A new, smart implant that “listens” to brain signals could help treat epilepsy and other neurological conditions, such as Parkinson’s disease. Could an innovative brain-stimulating device make a difference to the treatment of neurological conditions? Doctors use neurostimulation to treat various conditions, including epilepsy, the effects of stroke, and even depression. This treatment involves using special devices that send electrical […]

Is Tech The Answer For Seizure Patients?

Is Tech The Answer For Seizure Patients?

According to the CDC, over 3.4 million Americans – or 1.2 percent of the U.S. population – suffer from some form of epilepsy. Medication keeps some of these people’s seizures under control. The medications’ side effects, however, often make it difficult to function normally, and at least 30 percent of patients don’t respond to anti-seizure […]

New surgery treats epilepsy with deep-brain stimulation

New surgery treats epilepsy with deep-brain stimulation

Beginning Monday, patients with epilepsy will have a new option to reduce the number and severity of life-limiting seizures, avoiding radical surgery that removes a part of the brain. Called deep-brain stimulation, the treatment uses electrodes implanted in the thalamus, a structure located near the center of the brain that receives information from the senses […]

Neuroene Therapeutics awarded $1.5 million to develop anti-seizure compound for epilepsy

Neuroene Therapeutics awarded $1.5 million to develop anti-seizure compound for epilepsy

With funding from NIH Phase II SBIR grant, Neuroene Therapeutics will take the next steps toward bringing their vitamin K analogues for drug-resistant epilepsy to clinical trial Neuroene Therapeutics, a start-up company founded by mitochondrial biologist Sherine S. L. Chan, Ph.D. and medicinal chemist C. James Chou, Ph.D. of the Medical University of South Carolina, […]

LivaNova Launches Study to Assess VNS Therapy in Drug-resistant Epilepsy Patients

LivaNova Launches Study to Assess VNS Therapy in Drug-resistant Epilepsy Patients

September 12, 2018:  LivaNova PLC announced the first implanted patient and official launch of a global registry to evaluate the use of LivaNova’s Vagus Nerve Stimulation Therapy® (VNS Therapy) System for patients with drug-resistant epilepsy (DRE), which affects nearly one in three people with epilepsy.1 The Comprehensive Outcomes Registry in Subjects with Epilepsy Treated with […]

RECENT NEWS